Organization Profile

You just read:

Sanofi Announces Positive Phase 3 Results for Toujeo® (insulin glargine [rDNA origin] injection, 300 U/mL) in Japanese People with Uncontrolled Diabetes

News provided by

Sanofi Diabetes

Jun 14, 2014, 13:37 ET